In dementia care relying only on randomized controlled trials can leave out a large amount of strong research that reflects ...
Protocol fidelity and transparency about changes are essential to the credibility of randomised controlled trials In recent ...
A randomized cross-over pilot study in 10 amateur male triathletes found that a beetroot-based multi-ingredient nitrate ...
A new systematic review published in Brain, Behavior, and Immunity suggests that using cannabinoids does not have a single, ...
When IVUS did not outperform angiography for guiding percutaneous interventions in two trials, the results offered more questions than answers.
In an interview with Targeted Oncology, Naomi Haas, MD, discusses the evolving landscape of adjuvant and neoadjuvant immune ...
Objectives In the USA, an estimated 40–50 million operations are performed annually, with high rates of adverse events. Since the 1980s, report cards have been used for outcome measures and to improve ...
Across multiple studies, the motivation for using cannabis predicts outcomes as strongly as frequency of use. Among emerging ...
A new RCT tested text message CBT for generalised anxiety in young adults, with promising results. But is it ready for ...
‘Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease’ was published in the Cochrane Database of Systematic Reviews at ...
Studies must be adapted to fill the evidence gaps Pregnant and breastfeeding women have long been systematically excluded ...
The authors updated a diagnosis list to identify low-acuity emergency department visits by veterans and applied it to examine ...